## Abstract Interleukin (IL‐) 27 is a member of IL‐12 cytokine family with Th1‐promoting and anti‐inflammatory effects. IL‐27 has been shown to facilitate tumor‐specific cytotoxic T lymphocyte (CTL) induction against various tumors. However, IL‐27 suppresses cytokine production of lymphocytes and a
Enhancement of anti-tumor immunity through local modulation of CTLA-4 and GITR by dendritic cells
✍ Scribed by Scott K. Pruitt; David Boczkowski; Nicole de Rosa; N. Rebecca Haley; Michael A. Morse; Douglas S. Tyler; Jens Dannull; Smita Nair
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 529 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We have examined the anti-tumor effect in nude mice caused by human pancreatic cancer cells (AsPC-1) modified to secrete IL-2 or IL-4. Loss of tumorigenicity of cytokineproducing, but not wild-type, cells was observed despite their unaltered in vitro proliferation rates; and these anti-tumor effects
Nine different human melanomas and 16 clones, isolated from 2 of them, were characterized for susceptibility to rlLl-P-, rlL4-, rTNF-a-and rlFN-y-mediated effects on proliferation and surface expression of class-ll HLA (DR and DP), ICAM-I and LFA-3 molecules and of 3 tumor-associated antigens (recog